Suggestions
Stephen Martin
Global Head of Research at Boehringer Ingelheim Animal Health
Stephen Martin was previously the Global Head of Research at Boehringer Ingelheim Animal Health, but he has since left the company. He announced his departure from Boehringer-Ingelheim Animal Health in June 2023 after more than 30 years in the pharmaceutical and animal health industry.3
During his tenure at Boehringer Ingelheim Animal Health, Martin played a significant role in the company's research initiatives. He was involved in collaborative efforts to develop innovative solutions in animal health, including a partnership with MabGenesis to discover and develop novel monoclonal antibodies for potential canine therapeutic treatments.1
Martin has extensive knowledge and experience in all sectors of the biological and pharmaceutical business.2 His career spans over three decades, during which he worked for various prominent companies in the industry, including Merial, Novartis Animal Health, Upjohn, and Boehringer Ingelheim Animal Health.4
As of January 2025, Stephen Martin is self-employed, leveraging his vast experience in the pharmaceutical and animal health sectors.24
